Clever Leaves Holdings Inc. (CLVR) vs Talphera, Inc. (TLPH)

Clever Leaves Holdings Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Clever Leaves Holdings Inc. is the larger, with a market value of $96.5M against $55.5M — 1.7× the size. Clever Leaves Holdings Inc. grew revenue faster over the last twelve months: 6.14% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs −52.6%). Across the 17 metrics below, Talphera, Inc. leads on 9 and Clever Leaves Holdings Inc. on 8.

Valuation

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.00 191.48 2.11
P/B 0.00 5.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 0.44 n/m 12.58
EV/Sales (0.33) 166.32 2.73
Earnings yield (113,051.00%) (25.00%) (4.38%)
Free cash flow yield (55,338.01%) (11.83%) 0.00%

Profitability

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
Gross margin 37.64% 100.00% 53.94%
Operating margin (89.53%) 0.00% 0.00%
Net margin (102.77%) 0.00% 0.00%
Free cash flow margin (49.82%) 0.00% 0.00%
Return on equity (55.39%) (143.36%) (0.40%)
Return on assets (42.95%) (69.60%) (3.32%)
Return on invested capital (52.59%) 0.00% 0.00%

Growth

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.14% (73.07%) 10.01%
EPS growth (last fiscal year) 77.89% 32.00% 49.06%
Revenue growth, 5-year CAGR — (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.00 0.05
Current ratio 2.40 4.29 2.31
Net debt to EBITDA 0.45 1.50 0.97

Dividend

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CLVR TLPH Drug Manufacturers Specialty & Generic median
Market cap 96.49m 55.54m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack